CHE vs OPCH vs AVAH Stock Comparison

Chemed, Option Care Health and Aveanna Healthcare Holdings Prices as of Oct 26, 2026 Peers: Industry group
CHE Chemed Corp
$513.32 +0.3% 1M +17.6% 1Y
Market cap
$6.70B
P/E
24.4x
Revenue (TTM)
$2.60B
Div. yield
0.00%
Home Health and Senior Care Healthcare
5 wins
OPCH Option Care Health, Inc.
$31.23 +35.4% 1M +11.9% 1Y
Market cap
$4.79B
P/E
22.8x
Revenue (TTM)
$5.69B
Div. yield
–
Home Health and Senior Care Healthcare

Head to Head

11 decided of 12

Aveanna Healthcare Holdings leads on 6 of the 12 questions below (Aveanna Healthcare Holdings 6, Chemed 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCHEOPCHAVAHLeader
Larger companyMarket capitalisation $6.70B $4.79B $2.76B CHE
Cheaper on earningsLower P/E, profitable companies only 24.4x 22.8x 10.6x AVAH
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.4x 16.1x 15.5x AVAH
Faster revenue growthRevenue growth, trailing twelve months +3.3% +5.9% +16.8% AVAH
More profitableNet margin, trailing twelve months 10.6% 3.7% 10.2% CHE
Better return on capitalReturn on invested capital 27.2% 9.9% 18.4% CHE
Less leveragedLower net debt / EBITDA 0.2x 2.4x 4.0x CHE
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +17.6% +11.9% +39.8% AVAH
Better 5-year returnAnnualised price return, 5 years +3.1%/yr +3.2%/yr +12.7%/yr AVAH
Less volatileAnnualised volatility, 1 year 29.9% 52.1% 47.7% CHE
Higher overall scoreMean of the five percentile scores vs peers 59/100 53/100 66/100 AVAH

Percentile Scorecard

CHEOPCHAVAH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHEOPCHAVAH
Valuation 57 #41 of 93 79 #20 of 93 70 #29 of 93
Growth 14 #76 of 88 23 #68 of 88 84 #15 of 88
Profitability 92 #8 of 87 65 #31 of 87 91 #9 of 87
Financial Health 67 #34 of 100 44 #56 of 100 21 #79 of 100
Shareholder Returns 64 #21 of 56 – –
Overall 59 53 66
  • CHE ranked among 103 companies in Healthcare Providers
  • OPCH ranked among 103 companies in Healthcare Providers
  • AVAH ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHEOPCHAVAHSPY
1 month +0.3%+35.4%+6.2% -0.8%
3 months +0.9%+43.2%+36.3% +3.5%
6 months +21.4%+11.8%+95.3% +7.0%
Year to date +20.0%-2.0%+61.3% +12.2%
1 year +17.6%+11.9%+39.8% +13.0%
3 years -9.1%+17.3%+998.3% +86.3%
3 years, per year -3.1%+5.5%+122.4% +23.1%
5 years +16.2%+17.2%+81.8% +68.6%
5 years, per year +3.1%+3.2%+12.7% +11.0%
10 years +275.9%—— +258.0%
10 years, per year +14.2%—— +13.6%

Risk

MeasureCHEOPCHAVAHSPY
Volatility, 1Y 29.9%52.1%47.7% 12.7%
Downside volatility, 1Y 33.3%50.4%43.1% 12.7%
Beta vs S&P 500, 1Y 0.010.050.64 1.00
Return / volatility, 1Y 0.590.230.83 1.02
Max drawdown, 5Y -43.4%-46.7%-92.3% -25.4%
From 52-week high -7.1%-14.6%-8.3% -1.8%
52-week high $552.43$36.59$14.38 $779.14
52-week low $368.59$19.52$6.22 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHEOPCHAVAH
P/E now vs peer median 24.6xmedian 25.1x 22.8xmedian 25.1x 11.0xmedian 25.1x
P/S now vs peer median 2.6xmedian 1.6x 0.8xmedian 1.6x 1.1xmedian 1.6x
EV/EBITDA now vs peer median 16.4xmedian 14.5x 13.8xmedian 14.5x 13.6xmedian 14.5x
P/FCF now vs peer median 20.7xmedian 22.4x 15.4xmedian 22.4x —median 22.4x
P/B now vs peer median 8.1xmedian 3.1x 3.7xmedian 3.1x 10.0xmedian 3.1x
PEG now vs peer median 2.07median 0.66 22.06median 0.66 0.25median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHEOPCHAVAH
Revenue $2.60B $5.69B $2.54B
Gross profit $859.31M $1.09B $845.45M
Operating income $349.19M $333.69M $284.64M
Net income $274.99M $209.58M $260.11M
Free cash flow $323.61M $303.85M –
EPS (diluted) $20.83 $1.37 $1.16
Cash & equivalents $40.22M $193.77M $97.20M
Total debt $140.00M $1.16B $1.30B
Shares (diluted) 13.20M 153.49M 224.86M
Enterprise value $6.44B $3.87B $2.23B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHEOPCHAVAH
P/E 24.6x 22.8x 11.0x
P/FCF 20.7x 15.4x –
P/Operating cash flow 17.2x 13.5x –
P/S 2.6x 0.8x 1.1x
P/B 8.1x 3.7x 10.0x
P/Tangible book 8.9x 4.8x 15.3x
EV/EBITDA 16.4x 13.8x 13.6x
EV/EBIT 19.5x 16.9x 14.3x
EV/Revenue 2.6x 1.0x 1.6x
EV/FCF 21.0x 18.6x –
EV/Operating cash flow 17.5x 16.3x –
PEG (3Y EPS CAGR) 2.07 22.06 0.25

Growth

14 metrics
MetricCHEOPCHAVAH
Revenue growth (1Y) 3.3% 5.9% 16.8%
Revenue CAGR (3Y) 5.9% 11.3% 11.6%
Gross profit growth (1Y) 1.7% 2.6% 16.5%
Gross profit CAGR (3Y) 4.8% 5.3% 14.5%
Operating income growth (1Y) -5.3% -0.1% 34.5%
Operating income CAGR (3Y) 4.7% 6.3% 58.3%
Net income growth (1Y) -5.3% -0.8% 1,302%
Net income CAGR (3Y) 6.7% -4.4% 47.1%
EPS growth (1Y) 5.5% 6.1% 1,212%
EPS CAGR (3Y) 11.9% 1.0% 44.2%
Operating cash flow growth (1Y) -8.6% 24.0% –
Operating cash flow CAGR (3Y) 4.2% -3.8% –
Free cash flow growth (1Y) -12.9% 26.0% –
Free cash flow CAGR (3Y) 5.0% -4.7% –

Profitability

14 metrics
MetricCHEOPCHAVAH
Gross margin 33.1% 19.1% 33.2%
EBITDA margin 16.0% 7.2% 11.8%
Operating margin 13.5% 5.9% 11.2%
Pretax margin 14.2% 5.0% 6.0%
Net margin 10.6% 3.7% 10.2%
FCF margin 12.5% 5.3% –
Operating cash flow margin 15.0% 6.1% –
Return on equity 32.8% 16.0% 108.0%
Return on assets 17.7% 6.2% 12.6%
Return on invested capital 27.2% 9.9% 18.4%
Return on capital employed 28.2% 13.0% 17.3%
Asset turnover 1.7x 1.7x 1.2x
Cash conversion (OCF / net income) 1.4x 1.7x –
Stock comp / revenue 1.3% 0.7% –

Financial Health

11 metrics
MetricCHEOPCHAVAH
Debt / assets 8.9% 34.3% 61.6%
Debt / equity 0.2x 0.9x 4.5x
Net debt / EBITDA 0.2x 2.4x 4.0x
Debt / FCF 0.4x 3.8x –
Liabilities / assets 47.4% 62.7% 86.4%
Equity / assets 52.6% 37.3% 13.6%
Interest coverage 106.5x 6.2x 2.2x
Current ratio 0.9x 1.5x 1.2x
Quick ratio 0.7x 1.0x 1.1x
Cash ratio 0.1x 0.2x 0.2x
Altman Z-score 10.45 3.88 1.93

Shareholder Returns

7 metrics
MetricCHEOPCHAVAH
Dividend yield 0.5% – –
Net buyback yield 9.5% – –
Shareholder yield 10.0% – –
Payout ratio (earnings) 12.1% – –
Payout ratio (FCF) 10.3% – –
Dividend growth (1Y) 12.4% – –
Dividend CAGR (3Y) 13.5% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHEOPCHAVAH
Forward P/E 19.4xFY2026 16.1xFY2026 15.5xFY2026
EPS, next fiscal year $26.52FY2026 $1.94FY2026 $0.85FY2026
EPS growth, next FY +23.1%FY2026 +12.8%FY2026 +41.7%FY2026
EPS growth, the year after +8.0% +12.9% +11.8%
Revenue, next fiscal year $2.66BFY2026 $5.93BFY2026 $2.76BFY2026
Revenue growth, next FY +5.1%FY2026 +5.0%FY2026 +13.4%FY2026
Revenue growth, the year after +15.2% -2.1% +8.7%
CHE estimates →OPCH estimates →AVAH estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCHEOPCHAVAH
Held by institutions 100.0% 100.0% 92.5%
Institutions holding 527 372 215
Change in shares held, QoQ +2.8% -4.6% +1.8%
Institutions buying 276 212 151
Institutions selling 186 121 52
Buyers to sellers 1.48 1.75 2.90
CHE holders →OPCH holders →AVAH holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CHEOPCHAVAH
CHE 1.00 0.25 0.17
OPCH 0.25 1.00 0.13
AVAH 0.17 0.13 1.00

Add a Peer

Largest companies in the same industry
CHE · Home Health and Senior Care
+BTSGBrightSpring Health Services +ENSGEnsign +PACSPacs +NHCNational Healthcare +BKDBrookdale Senior Living +ADUSAddus HomeCare +SNDASonida Senior Living +PNTGPennant
Plot all 9 Home Health and Senior Care stocks →

Related Comparisons

CHE vs BTSGBrightSpring Health Services CHE vs ENSGEnsign CHE vs PACSPacs CHE vs NHCNational Healthcare

Frequently Asked Questions

Which is bigger, CHE, OPCH and AVAH?

Chemed (CHE) is the largest by market capitalisation: Chemed (CHE) $6.70B, Option Care Health (OPCH) $4.79B, Aveanna Healthcare Holdings (AVAH) $2.76B.

Which stock is cheaper, CHE, OPCH and AVAH?

Aveanna Healthcare Holdings (AVAH) trades on the lowest price-to-earnings ratio (Chemed (CHE) 24.4x, Option Care Health (OPCH) 22.8x, Aveanna Healthcare Holdings (AVAH) 10.6x). On next year's consensus earnings, Aveanna Healthcare Holdings (AVAH) is cheapest (Chemed (CHE) 19.4x, Option Care Health (OPCH) 16.1x, Aveanna Healthcare Holdings (AVAH) 15.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Aveanna Healthcare Holdings (AVAH) grew revenue fastest over the trailing twelve months: Chemed (CHE) +3.3%, Option Care Health (OPCH) +5.9%, Aveanna Healthcare Holdings (AVAH) +16.8%.

Which company is more profitable?

Chemed (CHE) has the highest net margin (Chemed (CHE) 10.6%, Option Care Health (OPCH) 3.7%, Aveanna Healthcare Holdings (AVAH) 10.2%). On return on invested capital, Chemed (CHE) leads (Chemed (CHE) 27.2%, Option Care Health (OPCH) 9.9%, Aveanna Healthcare Holdings (AVAH) 18.4%).

Which stock has performed better?

Over the past year Aveanna Healthcare Holdings (AVAH) returned the most: Chemed (CHE) +17.6%, Option Care Health (OPCH) +11.9%, Aveanna Healthcare Holdings (AVAH) +39.8%. Over five years, Aveanna Healthcare Holdings (AVAH) compounded fastest (Chemed (CHE) +3.1%/yr, Option Care Health (OPCH) +3.2%/yr, Aveanna Healthcare Holdings (AVAH) +12.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Chemed (CHE) 0.00%, Option Care Health (OPCH) 0.00%, Aveanna Healthcare Holdings (AVAH) 0.00%. Option Care Health (OPCH) and Aveanna Healthcare Holdings (AVAH) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Chemed (CHE) has been the steadiest (Chemed (CHE) 29.9%, Option Care Health (OPCH) 52.1%, Aveanna Healthcare Holdings (AVAH) 47.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CHE, OPCH and AVAH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Aveanna Healthcare Holdings (AVAH) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.